ESC Premium Access

Infusion of TRO40303 in patients with ST-elevation myocardial infarction prior to primary percutaneous coronary intervention did not alter levels of inflammatory biomarkers in the MITOCARE study

Congress Presentation

About the speaker

Doctor Noreen Butt

Stavanger University Hospital, Stavanger (Norway)
0 follower

26 more presentations in this session

Effects of statin therapy on plasma proprotein convertase subtilisin/kexin type 9 and sortilin levels in statin-naive patients with coronary artery disease

Speaker: Doctor T. Nozue (Yokohama, JP)

Thumbnail

Is routine combination of renin-angiotensin system blocker and beta blocker beneficial in low-risk myocardial infarction patients?

Thumbnail

Renalguard to prevent acute kidney injury in high risk patients undergoing coronary interventions

Speaker: Doctor V. Gritti (Cinisello Balsamo, IT)

Thumbnail

Benefit of early statin initiation within 48 hours after admission in patients with acute myocardial infarction

Speaker: Associate Professor M. Kim (Gwangju, KR)

Thumbnail

Prescription of statins and one year risk of major clinical outcomes among ACS patients with extremely low LDL-c (<70mg/dl): data from CPACS studies

Speaker: Doctor Y. Sun (Beijing, CN)

Thumbnail

Access the full session

Poster session 6 - Adjunctive medical therapy in coronary artery disease

Speakers: Doctor N. Butt, Doctor T. Nozue, Doctor V. Gritti, Associate Professor M. Kim, Doctor Y. Sun
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations